Barrier Isolators for Pharmaceutical Compounding Pharmacy Isolator Chambers for Compounding Sterile and Chemotherapy Preparations
    Barrier Isolators that Meet USP Chapter 797 Compliance
    for Pharmaceutical Compounding Applications
HOME       BARRIER ISOLATORS       USP 797 COMPLIANCE       ABOUT OUR COMPANY       CONTACT US

   BARRIER ISOLATORS
   » Intro to Barrier Isolators
   » A2 Barrier Isolator
   » A2 Isolator Benefits
   » Product Specification
   » Technical Data
   » Validation & QC Testing
   » Easy Change Cuff Ring
   » Options & Accessories
   » FAQs
   » Request a Quote


Request a Quote
   USP CHAPTER 797
   » Intro to USP 797
   » Risk Level Assessment
   » Gap Analysis
   » USP 797 Compliance
   » Sterile Compounding
   » Cleanroom Alternatives


   INNOVATIVE TECHNOLOGY
   » About Our Company
   » Industry Leaders
   » Customer Service

Home > A2 Pharmacy Isolator > Validation and QC Testing

A2 Pharmacy Isolator - Validation and QC Testing


Both transfer chambers and the process Isolator are fitted with test points for monitoring and validation. These are located in the front panel of the isolator. Test points are also provided for filter validation and at key stages throughout the Isolator System.

A2 Pharmacy Isolator - Validation and QC Testing Isolator integrity is demonstrated by means of a pressure hold test which is simple to carry out. The pressure hold test is carried out at 1000Pa for a negative pressure isolator and 250Pa for a positive pressure isolator. The test takes 10 minutes and is timed and monitored by the control system. Leak test bungs are placed over the air inlets and the air extracts to each isolator chamber. Placing the bungs in the correct order establishes the leak test pressure conditions and seals the isolator for the test. Once the test conditions are established the operator is asked to press a button on the control system to start the test.

If the change in pressure is within preset limits of the performance established during commissioning and validation of the isolator then the integrity of the isolator has been maintained. The control system will indicate a pass and the isolator returned to normal operating conditions by removal of the leak test bungs.


Learn More..
About how you can benefit from the ease, reliability & safety of the A2 Pharmacy Isolator to meet USP 797 compliance requirements.

Phone:
978-462-4415

Fax:
978-462-3338

Email:
Contact Us

Online:
Request Information
797 Compliance News
ARTICLE
What is a "compounded sterile preparation" according to USP Chapter 797?

ARTICLE
A2 Barrier Isolators as an Alternative to a Cleanroom.

ARTICLE
Using Barrier Isolators for Sterile Compounding: Meeting the new USP Chapter 797 and NIOSH environmental recommendations.

ARTICLE
Do I need a cleanroom like those used in a manufacturing environment?

ARTICLE
Innovative Technology's A2 Pharmacy Isolator meets Compliance with USP Chapter <797>.

WHITE PAPER
Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare facilities.


© Innovative Technology, Inc. · 2 New Pasture Road · Newburyport · MA · 01950 · USA
Phone: 978 462-4415 · Fax: 978 462-3338 · Email: A2@gloveboxes.com

Barrier Isolators | USP 797 Compliance | Innovative Technology | Contact Us